ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

38.03
Delayed Data
As of Apr 17
 -0.64 / -1.66%
Today’s Change
17.15
Today|||52-Week Range
46.48
+19.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-22.8M-20.8M-37.9M-92.5M
 
 
 
 
 
Depreciation285.0K109.0K79.0K206.0K
 
 
 
 
 
Total Other Cash Flow2.5M1.5M7.2M16.5M
 
 
 
 
 
Funds From Operations-20.0M-19.2M-30.6M-75.7M
 
 
 
 
 
Funds From/For Other Operating Expenses-74.0K2.4M1.1M-9.3M
 
 
 
 
 
Net Cash Flow - Operating Activities-19.9M-21.6M-31.8M-66.4M
 
 
 
 
 
 
InvestingIncrease In Investments-48.1M-56.7M-211.6M-335.4M
 
 
 
 
 
Decrease In Investments54.0M30.9M86.1M248.3M
 
 
 
 
 
Capital Expenditures-3.0K---618.0K-180.0K
 
 
 
 
Fixed Asset Disposal0.00252.0K12.0K0.00
 
 
 
Net Cash Flow Investing6.0M-25.5M-126.1M-87.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-78.0K-32.0K0.000.00
 
 
 
Net Proceeds Stock Sale14.0M98.2M111.7M203.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing13.9M98.2M111.7M203.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash13.0K-1.0K-1.0K3.0K
 
 
 
 
 
 
Net Change In Cash27.0K51.0M-46.2M50.1M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account